New World Medical Launches Ahmed ClearPath Glaucoma Drainage Device

Source: New World Medical

New World Medical announced the launch of the Ahmed ClearPath glaucoma drainage device, which is available in two sizes, 350 mm2 and 250 mm. A unique feature of the Ahmed ClearPath implant is a flexible plate with a contour that closely conforms to the curvature of the eye. In addition, the suture fixation points are positioned more anteriorly on the device compared to other valveless drainage devices. By making the suture points more visible and accessible, the surgeon may find securing this implant to the eye more convenient. The model 350 plate surface is positioned more posteriorly to avoid muscle attachment points, while the model 250 is designed to be a true-single quadrant implant that fits between the muscles. Finally, the device comes with an optional pre-threaded ripcord and a 23-GA needle.

“With the launch of the Ahmed ClearPath, we are excited to offer glaucoma patients another treatment option while making tube shunt surgery more convenient and efficient for surgeons,” Bilal Khan, President of New World Medical, said in a company news release. “We feel strongly that with every addition to New World Medical’s Ahmed brand, we are bringing effective glaucoma treatments to more patients to help preserve their sight.”

“The range and quality of surgical options available today are strengthening the fight against glaucoma, the world’s leading cause of permanent blindness,” Alyson L. Hall, MD, of The Glaucoma Center in Annapolis, Maryland, said in the news release. “We usually perform tube shunt surgery in patients whose glaucoma is not controlled by medications and who may have had previous surgeries. These are complex cases, so we welcome how the elegance of the Ahmed ClearPath design streamlines the procedure. When we suture in this implant, we can see what we’re doing and work more easily than we can with other implants, and I think that ultimately will improve the outcomes of tube shunt surgery.”

Ahmed ClearPath will be commercially available for purchase in the United States beginning August 22, 2019.

Related Content